KPIs & Operating Metrics(New)
Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueGoodwill & IntangiblesIntangiblesLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Ginkgo Bioworks Holdings (DNA) Other Non-Current Liabilities: 2020-2025

Historic Other Non-Current Liabilities for Ginkgo Bioworks Holdings (DNA) over the last 5 years, with Sep 2025 value amounting to $17.2 million.

  • Ginkgo Bioworks Holdings' Other Non-Current Liabilities fell 2.91% to $17.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $17.2 million, marking a year-over-year decrease of 2.91%. This contributed to the annual value of $16.6 million for FY2024, which is 32.16% down from last year.
  • Latest data reveals that Ginkgo Bioworks Holdings reported Other Non-Current Liabilities of $17.2 million as of Q3 2025, which was down 4.37% from $17.9 million recorded in Q2 2025.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Other Non-Current Liabilities peaked at $212.9 million during Q3 2021, and registered a low of $15.4 million during Q1 2025.
  • Over the past 3 years, Ginkgo Bioworks Holdings' median Other Non-Current Liabilities value was $19.3 million (recorded in 2023), while the average stood at $20.3 million.
  • As far as peak fluctuations go, Ginkgo Bioworks Holdings' Other Non-Current Liabilities surged by 4,380.15% in 2021, and later tumbled by 81.34% in 2022.
  • Over the past 5 years, Ginkgo Bioworks Holdings' Other Non-Current Liabilities (Quarterly) stood at $135.8 million in 2021, then plummeted by 77.04% to $31.2 million in 2022, then dropped by 21.67% to $24.4 million in 2023, then plummeted by 32.16% to $16.6 million in 2024, then dropped by 2.91% to $17.2 million in 2025.
  • Its last three reported values are $17.2 million in Q3 2025, $17.9 million for Q2 2025, and $15.4 million during Q1 2025.